Mutated non-primate lentiviral Env proteins and their use as drugs
US9974852B2 · kind B2 · utility
0Cited by
0References
23Claims
0Family size
Assignees
Inventor
Key dates
| Filing date | Jun 6, 2014 |
| Grant date | May 22, 2018 |
| Priority date | — |
| Expiry date | Jun 6, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/15034
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical composition includes, as active substance a mutated non-primate lentiviral Env protein having decreased immunosuppressive properties, substantially no immunosuppressive properties or no immunosuppressive properties, or a variant of the mutated lentiviral Env protein, or a fragment of the above proteins, in association with a pharmaceutically acceptable carrier.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.